Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bel20 | BEL20 | May 20, 2024 | 4 006.94 | +0.05 |
Belreca - Belgian Resources and Capital Company | BELR | May 20, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | May 20, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | May 20, 2024 | 0.88 | -0.57 |
Biocartis Group NV | BCART | May 20, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | May 20, 2024 | 0.02 | +4.43 |
Biotalys | BTLS | May 20, 2024 | 3.08 | +0.98 |
Boeing | BOEI | May 20, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 20, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 20, 2024 | 3.37 | +1.05 |
Brederode S.A. | BREB | May 20, 2024 | 113.20 | -0.70 |
Campine nv | CAMB | May 20, 2024 | 77.50 | +0.65 |
Candela Invest | CAND | May 20, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 20, 2024 | 14.96 | -0.40 |
Celyad Oncology SA | CYAD | May 20, 2024 | 0.32 | +1.44 |
Cenergy Holdings | CENER | May 20, 2024 | 8.50 | -2.75 |
Chevron | CHTEX | May 20, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 20, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 20, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 20, 2024 | 61.70 | -0.56 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 20, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 20, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 20, 2024 | 43.52 | +0.09 |
Compagnie du Bois Sauvage S.A. | COMB | May 20, 2024 | 272.00 | +2.26 |
Compagnie d`Entreprises CFE SA | CFEB | May 20, 2024 | 7.65 | +0.13 |
Connect Group | CONN | May 20, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | May 20, 2024 | 0.01 | -3.08 |
Cumulex NV | CLEX | May 20, 2024 | 1.15 | 0.00 |
CURETIS | CURE | May 20, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | May 20, 2024 | 2.56 | +0.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.